Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?
J Diabetes Sci Technol
; 14(4): 745-747, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-505675
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Diabetes Mellitus, Type 1
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Diabetes Sci Technol
Journal subject:
Endocrinology
Year:
2020
Document Type:
Article
Affiliation country:
1932296820932155
Similar
MEDLINE
...
LILACS
LIS